{"disease":{"id":"transplant-related-hematologic-malignancy","name":"transplant related hematologic malignancy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04237623","title":"GM-CSF With Post-Transplant Cyclophosphamide","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":38,"lead_sponsor_name":"Northside Hospital, Inc.","has_results":false},{"nct_id":"NCT05164016","title":"Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients","phase":"","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT03131934","title":"Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":18,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03961919","title":"Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic Transplant","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Ciceri Fabio","has_results":false},{"nct_id":"NCT03434704","title":"Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Ciceri Fabio","has_results":false},{"nct_id":"NCT03963024","title":"Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}